Neuropathological correlates of volumetric MRI in autopsy-confirmed Lewy body dementia

Neurobiology of Aging

Volumn 33, Issue 7, 2012, Pages 1228-1236

  Burton, Emma J ^a   Mukaetova Ladinska, Elizabeta B ^a   Perry, Robert H ^a,b   Jaros, Evelyn ^a,b   Barber, Robert ^a   O'Brien, John T ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Amygdala; Lewy body dementia; MRI; Neuropathology

Indexed keywords

AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; AUTOPSY; BRAIN ATROPHY; BRAIN REGION; BRAIN SIZE; CLINICAL ARTICLE; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; LEWY BODY; LINEAR REGRESSION ANALYSIS; MALE; MEDIAL TEMPORAL LOBE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENILE PLAQUE; TEMPORAL LOBE; VOLUMETRY;

AGED; AGED, 80 AND OVER; AUTOPSY; BRAIN; FEMALE; HUMANS; LEWY BODY DISEASE; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; ORGAN SIZE; PROSPECTIVE STUDIES;

EID: 84861197364     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2010.12.015     Document Type: Article

References (64)

1. Aarsland D., Ballard C.G., Halliday G. Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity?. J. Geriatr. Psychiatry Neurol 2004, 17:137-145.
2. Andreescu C., Butters M.A., Begley A., Rajji T., Wu M., Meltzer C.C., Reynolds C.F., Aizenstein H. Gray matter changes in late life depression-a structural MRI analysis. Neuropsychopharmacology 2008, 33:2566-2572.
3. Armstrong R.A., Cairns N.J., Lantos P.L. Beta-amyloid deposition in the temporal lobe of patients with dementia with Lewy bodies: comparison with non-demented cases and Alzheimer's disease. Dement. Geriatr. Cogn. Disord 2000, 11:187-192.
4. Ballard C., McKeith I., Burn D., Harrison R., O'Brien J., Lowery K., Campbell M., Perry R., Ince P. The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies. Acta Neurol. Scand 1997, 96:366-371.
5. Barber R., Ballard C., McKeith I.G., Gholkar A., O'Brien J.T. MRI volumetric study of dementia with Lewy bodies: a comparison with AD and vascular dementia. Neurology 2000, 54:1304-1309.
6. Barber R., Gholkar A., Scheltens P., Ballard C., McKeith I.G., O'Brien J.T. Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology 1999, 52:1153-1158.
7. Barber R., McKeith I.G., Ballard C., Gholkar A., O'Brien J.T. A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: magnetic resonance imaging volumetric study. Dement. Geriatr. Cogn. Disord 2001, 12:198-205.
8. Barnes J., Whitwell J.L., Frost C., Josephs K.A., Rossor M., Fox N.C. Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration. Arch. Neurol 2006, 63:1434-1439.
9. Beach T.G., Adler C.H., Lue L., Sue L.I., Bachalakuri J., Henry-Watson J., Sasse J., Boyer S., Shirohi S., Brooks R., Eschbacher J., White C.L., Akiyama H., Caviness J., Shill H.A., Connor D.J., Sabbagh M.N., Walker D.G. Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 2009, 117:613-634. 6.
10. Beyer M.K., Larsen J.P., Aarsland D. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Neurology 2007, 69:747-754.
11. Bobinski M., de Leon M.J., Convit A., De Santi S., Wegiel J., Tarshish C.Y., Saint-Louis L.A., Wisniewski H.M. MRI of entorhinal cortex in mild Alzheimer's disease. Lancet 1999, 353:38-40.
12. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
13. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen-Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 2003, 24:97-211.
14. Burton E.J., Barber R., Mukaetova-Ladinska E.B., Robson J., Perry R.H., Jaros E., Kalaria R.N., O'Brien J.T. Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis. Brain 2009, 132:195-203.
15. Burton E.J., Karas G., Paling S.M., Barber R., Williams E.D., Ballard C.G., McKeith I.G., Scheltens P., Barkhof F., O'Brien J.T. Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry. Neuroimage 2002, 17:618-630.
16. Burton E.J., McKeith I.G., Burn D.J., Williams E.D., O'Brien J.T. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 2004, 127:791-800.
17. Cordato N.J., Halliday G.M., Harding A.J., Hely M.A., Morris J.G. Regional brain atrophy in progressive supranuclear palsy and Lewy body disease. Ann. Neurol 2000, 47:718-728.
18. Cousins D.A., Burton E.J., Burn D., Gholkar A., McKeith I.G., O'Brien J.T. Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer's disease: an MRI study. Neurology 2003, 61:1191-1195.
19. Crystal H.A., Dickson D.W., Sliwinski M.J., Lipton R.B., Grober E., Marks-Nelson H., Antis P. Pathological markers associated with normal aging and dementia in the elderly. Ann. Neurol 1993, 34:566-573.
20. Csernansky J.G., Hamstra J., Wang L., McKeel D., Price J.L., Gado M., Morris J.C. Correlations between antemortem hippocampal volume and postmortem neuropathology in AD subjects. Alzheimer Dis. Assoc. Disord 2004, 18:190-195.
21. Dickson D.W., Crystal H., Mattiace L.A., Kress Y., Schwagerl A., Ksiezak-Reding H., Davies P., Yen S.H. Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropathol 1989, 78:572-584.
22. Du A.T., Schuff N., Zhu X.P., Jagust W.J., Miller B.L., Reed B.R., Kramer J.H., Mungas D., Yaffe K., Chui H.C., Weiner M.W. Atrophy rates of entorhinal cortex in AD and normal aging. Neurology 2003, 60:481-486.
23. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res 1975, 12:189-198.
24. Freeborough P.A., Fox N.C., Kitney R.I. Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. Comput. Methods Programs Biomed 1997, 53:15-25.
25. Galton C.J., Patterson K., Graham K., Lambon-Ralph M.A., Williams G., Antoun N., Sahakian B.J., Hodges J.R. Differing patterns of temporal atrophy in Alzheimer's disease and semantic dementia. Neurology 2001, 57:216-225.
26. Good C.D., Scahill R.I., Fox N.C., Ashburner J., Friston K.J., Chan D., Crum W.R., Rossor M.N., Frackowiak R.S.J. Automatic differentiation of anatomical patterns in the human brain: Validation with studies of degenerative dementias. Neuroimage 2002, 17:29-46.
27. Gosche K.M., Mortimer J.A., Smith C.D., Markesbery W.R., Snowdon D.A. Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study. Neurology 2002, 58:1476-1482.
28. Hamilton R.L. Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol 2000, 10:378-384.
29. Harding A.J., Broe G.A., Halliday G.M. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 2002, 125:391-403.
30. Hashimoto M., Kitagaki H., Imamura T., Hirono N., Shimomura T., Kazui H., Tanimukai S., Hanihara T., Mori E. Medial temporal and whole-brain atrophy in dementia with Lewy bodies: a volumetric MRI study. Neurology 1998, 51:357-362.
31. Huesgen C.T., Burger P.C., Crain B.J., Johnson G.A. In vitro MR microscopy of the hippocampus in Alzheimer's disease. Neurology 1993, 43:145-152.
32. Jack C.R., Dickson D.W., Parisi J.E., Xu Y.C., Cha R.H., O'Brien P.C., Edland S.D., Smith G.E., Boeve B.F., Tangalos E.G., Kokmen E., Petersen R.C. Ante mortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 2002, 58:750-757.
33. Junque C., Ramirez-Ruiz B., Tolosa E., Summerfield C., Marti M.J., Pastor P., Gomez-Anson B., Mercader J.M. Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia. Mov. Disord 2005, 20:540-544.
34. Kantarci K., Avula R., Senjem M.L., Samikoglu A.R., Zhang B., Weigand S.D., Przybelski S.A., Edmonson H.A., Vemuri P., Knopman D.S., Ferman T.J., Boeve B.F., Petersen R.C., Jack C.R. Dementia with Lewy bodies and Alzheimer disease: neurodegenerative patterns characterized by DTI. Neurology 2010, 74:1814-1821.
35. Karas G.B., Burton E.J., Rombouts S.A., van Schijndel R.A., O'Brien J.T., Scheltens P., McKeith I.G., Williams D., Ballard C., Barkhof F. A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry. Neuroimage 2003, 18:895-907.
36. Keller J., Shen L., Gomez R.G., Garrett A., Solvason H.B., Reiss A., Schatzberg A.F. Hippocampal and amygdalar volumes in psychotic and nonpsychotic unipolar depression. Am. J. Psychiatry 2008, 165:872-880.
37. Kenny E.R., Burton E.J., O'Brien J.T. A volumetric magnetic resonance imaging study of entorhinal cortex volume in dementia with Lewy bodies. A comparison with Alzheimer's disease and Parkinson's disease with and without dementia. Dement. Geriatr. Cogn. Disord 2008, 26:218-225.
38. Killiany R.J., Gomez-Isla T., Moss M., Kikinis R., Sandor T., Jolesz F., Tanzi R., Jones K., Hyman B.T., Albert M.S. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann. Neurol 2000, 47:430-439.
39. Killiany R.J., Hyman B.T., Gomez-Isla T., Moss M.B., Kikinis R., Jolesz F., Tanzi R., Jones K., Albert M.S. MRI measures of entorhinal cortex vs hippocampus in preclinical. Adv. Neurol 2002, 58:1188-1196.
40. Lewis H., Beher D., Cookson N., Oakley A., Piggott M., Morris C.M., Jaros E., Perry R., Ince P., Kenny R.A., Ballard C.G., Shearman M.S., Kalaria R.N. Quantification of Alzheimer pathology in ageing and dementia: age-related accumulation of amyloid-beta(42) peptide in vascular dementia. Neuropathol. Appl. Neurobiol 2006, 32:103-118.
41. Lippa C.F., Duda J.E., Grossman M., Hurtig H.I., Aarsland D., Boeve B.F., Brooks D.J., Dickson D.W., Dubois B., Emre M., Fahn S., Farmer J.M., Galasko D., Galvin J.E., Goetz C.G., Growdon J.H., Gwinn-Hardy K.A., Hardy J., Heutink P., Iwatsubo T., Kosaka K., Lee V.M., Leverenz J.B., Masliah E., McKeith I.G., Nussbaum R.L., Olanow C.W., Ravina B.M., Singleton A.B., Tanner C.M., Trojanowski J.Q., Wszolek Z.K. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology 2007, 68:812-819.
42. Lippa C.F., Johnson R., Smith T.W. The medial temporal lobe in dementia with Lewy bodies: a comparative study with Alzheimer's disease. Ann. Neurol 1998, 43:102-106.
43. Mann D.M., Brown S.M., Owen F., Baba M., Iwatsubo T. Amyloid beta protein (A beta) deposition in dementia with Lewy bodies: predominance of A beta 42(43) and paucity of A beta 40 compared with sporadic Alzheimer's disease. Neuropathol. Appl. Neurobiol 1998, 24:187-194.
44. McKeel D.W., Price J.L., Miller J.P., Grant E.A., Xiong C., Berg L., Morris J.C. Neuropathologic criteria for diagnosing Alzheimer disease in persons with pure dementia of Alzheimer type. J. Neuropathol. Exp. Neurol 2004, 63:1028-1037.
45. McKeith I.G., Dickson D.W., Lowe J., Emre M., O'Brien J.T., Feldman H., Cummings J., Duda J.E., Lippa C., Perry E.K., Aarsland D., Arai H., Ballard C.G., Boeve B., Burn D.J., Costa D., Del Ser T., Dubois B., Galasko D., Gauthier S., Goetz C.G., Gomez-Tortosa E., Halliday G., Hansen L.A., Hardy J., Iwatsubo T., Kalaria R.N., Kaufer D., Kenny R.A., Korczyn A., Kosaka K., Lee V.M., Lees A., Litvan I., Londos E., Lopez O.L., Minoshima S., Mizuno Y., Molina J.A., Mukaetova-Ladinska E.B., Pasquier F., Perry R.H., Schulz J.B., Trojanowski J.Q., Yamada M. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005, 65:1863-1872.
46. McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A., Salmon D.P., Lowe J., Mirra S.S., Byrne E.J., Lennox G., Quinn N.P., Edwardson J.A., Ince P.G., Bergeron C., Burns A., Miller B.L., Lovestone S., Collerton D., Jansen E.N., Ballard C., de Vos R.A., Wilcock G.K., Jellinger K.A., Perry R.H. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996, 47:1113-1124.
47. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991, 41:479-486.
48. Parkkinen L., Soininen H., Alafuzoff I. Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease. J. Neuropathol. Exp. Neurol 2003, 62:363-367.
49. Pennanen C., Kivipelto M., Tuomainen S., Hartikainen P., Hanninen T., Laakso M.P., Hallikainen M., Vanhanen M., Nissinen A., Helkala E.L., Vainio P., Vanninen R., Partanen K., Soininen H. Hippocampus and entorhinal cortex in mild cognitive impairment and early ad. Neurobiol. Aging 2004, 25:303-310.
50. Perry R.H., Irving D., Blessed G., Fairbairn A., Perry E.K. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J. Neurol. Sci 1990, 95:119-139.
51. Perry R.H., Jaros E.B., Irving D., Scoones D.L., Brown A., McMeekin W.M., Perry E.K., Morris C.M., Kelly P.J., Ince P.J. What is the neuropathological basis of dementia associated with Lewy bodies. Dementia with Lewy bodies 1996, 212-223. Cambridge University Press, Cambridge. R.H. Perry, I.G. McKeith, E.K. Perry (Eds.).
52. Roth M., Tym E., Mountjoy C.Q., Huppert F.A., Hendrie H., Verma S., Goddard R. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br. J. Psychiatry 1986, 149:698-709.
53. Sahin H.A., Emre M., Ziabreva I., Perry E., Celasun B., Perry R. The distribution pattern of pathology and cholinergic deficits in amygdaloid complex in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol. 2006, 111:115-125.
54. Sanchez-Castaneda C., Rene R., Ramirez-Ruiz B., Campdelacreu J., Gascon J., Falcon C., Calopa M., Jauma S., Juncadella M., Junque C. Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson's disease with dementia. Mov. Disord 2009, 24:1740-1746.
55. Scahill R.I., Frost C., Jenkins R., Whitwell J.L., Rossor M.N., Fox N.C. A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch. Neurol 2003, 60:989-994.
56. Scheltens P., Leys D., Barkhof F., Huglo D., Weinstein H.C., Vermersch P., Kuiper M., Steinling M., Wolters E.C., Valk J. Atrophy of Medial Temporal Lobes on MRI in Probable Alzheimer's Disease and Normal Aging-Diagnostic-Value and Neuropsychological Correlates. J. Neurol. Neurosurg. Psychiatry 1992, 55:967-972.
57. Summerfield C., Junque C., Tolosa E., Salgado-Pineda P., Gomez-Anson B., Marti M.J., Pastor P., Ramirez-Ruiz B., Mercader J. Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. Arch. Neurol 2005, 62:281-285.
58. Tsuang D., Larson E.B., Bolen E., Thompson M.L., Peskind E., Bowen J., McCormick W., Teri L., Kukull W., Vavrek D., Montine T., Leverenz J.B. Visual hallucinations in dementia: a prospective community-based study with autopsy. Am. J. Geriatr. Psychiatry 2009, 17:317-323.
59. Tsuang D.W., Riekse R.G., Purganan K.M., David A.C., Montine T.J., Schellenberg G.D., Steinbart E.J., Petrie E.C., Bird T.D., Leverenz J.B. Lewy body pathology in late-onset familial Alzheimer's disease: a clinicopathological case series. J. Alzheimers Dis 2006, 9:235-242.
60. Tsuboi Y., Uchikado H., Dickson D.W. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology. Parkinsonism Relat. Disord 2007, 13:S221-S224.
61. Watson C., Andermann F., Gloor P., Jones-Gotman M., Peters T., Evans A., Olivier A., Melanson D., Leroux G. Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging. Neurology 1992, 42:1743-1750.
62. Whitwell J.L., Sampson E.L., Watt H.C., Harvey R.J., Rossor M.N., Fox N.C. A volumetric magnetic resonance imaging study of the amygdala in frontotemporal lobar degeneration and Alzheimer's disease. Dement. Geriatr. Cogn. Disord 2005, 20:238-244.
63. Whitwell J.L., Weigand S.D., Shiung M.M., Boeve B.F., Ferman T.J., Smith G.E., Knopman D.S., Petersen R.C., Benarroch E.E., Josephs K.A., Jack C.R. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. Brain 2007, 130:708-719.
64. Zaccai J., Brayne C., McKeith I., Matthews F., Ince P.G. Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort. Neurology 2008, 70:1042-1048.